Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial.
Chmielecki J, Mok T, Wu YL, Han JY, Ahn MJ, Ramalingam SS, John T, Okamoto I, Yang JC, Shepherd FA, Bulusu KC, Laus G, Collins B, Barrett JC, Hartmaier RJ, Papadimitrakopoulou V.
Chmielecki J, et al. Among authors: shepherd fa.
Nat Commun. 2023 Feb 27;14(1):1071. doi: 10.1038/s41467-023-35962-x.
Nat Commun. 2023.
PMID: 36849516
Free PMC article.